01 Sep 2021 ExeVir announces first patient enrolled in phase 1b/2 clinical study evaluating XVR011 as antiviral treatment of patients hospitalised for COVID-19 Member news
31 Aug 2021 Sequana Medical appoints Jackie Fielding, former Medtronic VP, to its Board of Directors Member news
30 Aug 2021 Bone Therapeutics announces topline results from Phase III knee osteoarthritis study with its enhanced viscosupplement JTA-004 Member news
25 Aug 2021 argenx announces validation of European marketing authorization application for Efgartigimod in generalized myasthenia gravis Member news
17 Aug 2021 Publication of Positive Phase 1 Clinical Data evaluating THR-687 for Treatment of DME in Ophthalmology Science Member news
17 Aug 2021 Precirix enters into alliance with 3P Biopharmaceuticals for the manufacturing of single domain antibodies Member news
28 Jul 2021 Bone Therapeutics agrees final settlement with the FSMA regarding clinical studies communication issues in 2016 and 2017 Member news
27 Jul 2021 eTheRNA immunotherapies appoints Mathieu Lane as Chief Financial Officer and President of eTheRNA Inc. located in the U.S.A Member news
More info? Ellen Telleir Communication Coordinator linkedin.com/in/ellentelleir/ +32 9 241 80 41 ellen.telleir@flanders.bio Contact us
